EP0210351A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Use of porphyrin derivatives in the detection and treatment of tumours
Assignee: Eneos Corp
•
Filing: 1986-04-30
•
Granted: —
•
Expires: 2006-04-30
Abstract
Abstract This invention relates to a therapeutic composition for detection and/ortreatment of mammalian tumors which comprises at least one fluorescent porphyrin containing at least three carboxylic acid groups or pharmaceutically acceptable salts thereof.
Inventors
- 👤 Jerry C. Bommer
- 👤 Bruce F. Burnham
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-26 17:06
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/0474; A61K51/0485; A61K31/00; A61K31/33; A61K31/395; A61K31/40; A61P; A61P35/00; A61P43/00; A61K2123/00
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
30 words
A therapeutic composition for detection and/or treatment of mammalian tumors which comprises at least one fluorescent porphyrin containing at least three carboxylic acid groups or a pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim
30 words
A therapeutic composition for detection and/or treatment of mammalian tumors which comprises at least one fluorescent porphyrin containing at least three carboxylic acid groups or a pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim
15 words
The therapeutic composition according to Claim 1 wherein the porphyrin contains three carboxylic acid groups.
Claim 4
Dependent Claim
21 words
The therapeutic composition according to Claim 2 wherein the three carboxylic acid groups are asymmetrically attached to the porphyrin ring system.
Claim 5
Dependent Claim
46 words
A therapeutic composition for detection and/or treatment of mammalian tumors which comprises at least one fluorescent compound of the formula: wherein; . X = H, vinyl, ethyl, acetyl or formyl; Y = methyl or formyl; M = methyl; and E = ethyl and pharmaceutically-acceptable salts thereof.
Claim 6
Dependent Claim
46 words
A therapeutic composition for detection and/or treatment of mammalian tumors which comprises at least one fluorescent compound of the formula: wherein; . X = H, vinyl, ethyl, acetyl or formyl; Y = methyl or formyl; M = methyl; and E = ethyl and pharmaceutically-acceptable salts thereof.
Claim 7
Dependent Claim
45 words
A therapeutic composition according to Claim 4 wherein the porphyrin compound is chlorin e 6 , mesochlorin e 6 , bacteriochlorin e 6 , 2-desvinylchlorin e 6 , mesochlorin e 6 , 2-acetylchlorin e 6 , 2-formylchlorin e 6 , or rhodin g 7 .
Claim 8
Dependent Claim
31 words
Use of a fluorescent porphyrin containing at least three carboxylic acid groups or pharmaceutically acceptable salts thereof for the preparation of a therapeutic composition for detection and/or treatment of mammalian tumors.
Claim 9
Dependent Claim
31 words
Use of a fluorescent porphyrin containing at least three carboxylic acid groups or pharmaceutically acceptable salts thereof for the preparation of a therapeutic composition for detection and/or treatment of mammalian tumors.
References Cited (Backward Citations)
JPS51125737A
Cited
WO1983000811A1
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.